Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Eton Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −1 vs. Q4 2021
- Shares held
- 5.78M
- +52.5K (+0.9%) vs. Q4 2021
- Total value
- $27.4M
- +$3.29M (+13.7%) vs. Q4 2021
- New holders
- 7
- 7 more added
- Sold out
- 8
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 23 | $0 | 0.00% | +23 | New |
| BNP Paribas Arbitrage, SA | 350 | $1.53K | 0.00% | −358−50.6% | Reduced |
| Plante Moran Financial Advisors, LLC | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,338 | $6.00K | 0.00% | +1,338 | New |
| UBS Group AG | 4,555 | $20.0K | 0.00% | +476+11.7% | Added |
| Wells Fargo & Company | 7,624 | $34.0K | 0.00% | +7,500+6,048.4% | Added |
| Belvedere Trading LLC | 10,876 | $43.0K | 0.03% | +10,876 | New |
| Financial Advisors Network, Inc. | 10,633 | $46.0K | 0.01% | 00.0% | Unchanged |
| Chicago Trust Co NA | 16,700 | $73.0K | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 17,610 | $77.0K | 0.00% | +17,610 | New |
| Susquehanna Fundamental Investments, LLC | 21,269 | $93.0K | 0.00% | −7,292−25.5% | Reduced |
| PDT Partners, LLC | 23,420 | $102.0K | 0.01% | +23,420 | New |
| JPMorgan Chase & Co | 24,273 | $106.0K | 0.00% | +24,273 | New |
| Gsa Capital Partners LLP | 24,475 | $107.0K | 0.01% | −15,342−38.5% | Reduced |
| Group One Trading, L.P. | 26,319 | $115.0K | 0.00% | −12,481−32.2% | Reduced |
| Morgan Stanley | 28,071 | $122.0K | 0.00% | −2,001−6.7% | Reduced |
| Northern Trust Corp | 30,355 | $132.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 38,932 | $170.0K | 0.00% | −5,068−11.5% | Reduced |
| Bank of New York Mellon Corp | 79,455 | $346.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 91,603 | $399.0K | 0.00% | +7,831+9.3% | Added |
| Paradigm Capital Management Inc | 100,000 | $436.0K | 0.02% | +10,000+11.1% | Added |
| First Citizens Bank & Trust Co | 100,000 | $436.0K | 0.02% | +100,000 | New |
| Geode Capital Management, LLC | 186,971 | $815.0K | 0.00% | +11,118+6.3% | Added |
| Bridgeway Capital Management, LLC | 225,163 | $982.0K | 0.02% | +21,900+10.8% | Added |
| BlackRock Inc. | 296,539 | $1.29M | 0.00% | −2,403−0.8% | Reduced |
| Roumell Asset Management, LLC | 449,438 | $1.96M | 3.17% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 472,588 | $2.06M | 0.27% | −27,412−5.5% | Reduced |
| Westside Investment Management, Inc. | 242,220 | $3.21M | 0.04% | +123,695+104.4% | Added |
| Vanguard Group Inc | 872,871 | $3.81M | 0.00% | −5,531−0.6% | Reduced |
| Opaleye Management Inc. | 2,379,275 | $10.4M | 3.22% | −5,725−0.2% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −92,092−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −42,240−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −22,642−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,593−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −15,190−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,212−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −328−100.0% | Sold out |